[PDF][PDF] Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease
…, FJ Calero-Nieto, R Doffinger, G Dougan, A Elmer… - Immunity, 2021 - cell.com
The kinetics of the immune changes in COVID-19 across severity groups have not been
rigorously assessed. Using immunophenotyping, RNA sequencing, and serum cytokine analysis…
rigorously assessed. Using immunophenotyping, RNA sequencing, and serum cytokine analysis…
Brain injury in COVID-19 is associated with dysregulated innate and adaptive immune responses
, … Research Facility Saunders Caroline Elmer Anne - Brain, 2022 - academic.oup.com
COVID-19 is associated with neurological complications including stroke, delirium and
encephalitis. Furthermore, a post-viral syndrome dominated by neuropsychiatric symptoms is …
encephalitis. Furthermore, a post-viral syndrome dominated by neuropsychiatric symptoms is …
[PDF][PDF] Combined point-of-care nucleic acid and antibody testing for SARS-CoV-2 following emergence of D614G spike variant
…, P Bundi, R Abeseabe, S Clark, I Vicente, A Elmer… - Cell Reports …, 2020 - cell.com
Rapid COVID-19 diagnosis in the hospital is essential, although this is complicated by 30%–50%
of nose/throat swabs being negative by SARS-CoV-2 nucleic acid amplification testing (…
of nose/throat swabs being negative by SARS-CoV-2 nucleic acid amplification testing (…
[HTML][HTML] SARS-CoV-2 B. 1.1. 7 sensitivity to mRNA vaccine-elicited, convalescent and monoclonal antibodies
…, MS Pizzuto, AF Pellanda, C Garzoni, A Riva, A Elmer… - MedRxiv, 2021 - ncbi.nlm.nih.gov
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) transmission is uncontrolled
in many parts of the world, compounded in some areas by higher transmission potential …
in many parts of the world, compounded in some areas by higher transmission potential …
[PDF][PDF] SARS-CoV-2 spike N-terminal domain modulates TMPRSS2-dependent viral entry and fusogenicity
…, A Bucke, J Calder, L Canna, J Domingo, A Elmer… - Cell Reports, 2022 - cell.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike N-terminal domain
(NTD) remains poorly characterized despite enrichment of mutations in this region across …
(NTD) remains poorly characterized despite enrichment of mutations in this region across …
SARS-CoV-2 B. 1.1. 7 escape from mRNA vaccine-elicited neutralizing antibodies
…, M Pizzuto, A Pallanda, C Gorzoni, A Riva, A Elmer… - 2021 - researchsquare.com
SARS-CoV-2 transmission is uncontrolled in many parts of the world, compounded in some
areas by higher transmission potential of the B1. 1.7 variant now seen in 50 countries. It is …
areas by higher transmission potential of the B1. 1.7 variant now seen in 50 countries. It is …
Impact of SARS-CoV-2 B. 1.1. 7 Spike variant on neutralisation potency of sera from individuals vaccinated with Pfizer vaccine BNT162b2
…, MS Pizzuto, AF Pellanda, C Garzoni, A Riva, A Elmer… - 2021 - pesquisa.bvsalud.org
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) transmission is uncontrolled
in many parts of the world, compounded in some areas by higher transmission potential …
in many parts of the world, compounded in some areas by higher transmission potential …
[HTML][HTML] Multivariate profile and acute-phase correlates of cognitive deficits in a COVID-19 hospitalised cohort
…, JG Outtrim, B Warne, J Bhatti, L Pointon, A Elmer… - …, 2022 - thelancet.com
Background Preliminary evidence has highlighted a possible association between severe
COVID-19 and persistent cognitive deficits. Further research is required to confirm this …
COVID-19 and persistent cognitive deficits. Further research is required to confirm this …
Age-related heterogeneity in neutralising antibody responses to SARS-CoV-2 following BNT162b2 vaccination
…, A Elmer… - MedRxiv, 2021 - medrxiv.org
Background Vaccines remain the cornerstone for containing the SARS-CoV-2 pandemic.
mRNA vaccines provide protection in clinical trials using a two-dose approach, separated by a …
mRNA vaccines provide protection in clinical trials using a two-dose approach, separated by a …
[HTML][HTML] Age-associated B cells predict impaired humoral immunity after COVID-19 vaccination in patients receiving immune checkpoint blockade
…, A Craxton, GSF Anderson, XM Sun, A Elmer… - Nature …, 2023 - nature.com
Age-associated B cells (ABC) accumulate with age and in individuals with different
immunological disorders, including cancer patients treated with immune checkpoint blockade and …
immunological disorders, including cancer patients treated with immune checkpoint blockade and …
